Is Absolute Lymphocyte Count a Good Prognostic Predictor in Recurrence of Hepatocellular Carcinoma after Liver Transplantation?

Chuan Li,Tian-Fu Wen,Lu-Nan Yan

DOI: https://doi.org/10.1097/tp.0000000000000036

2014-01-01

Transplantation

Abstract:We read with great interest the report by Nagai et al. (1), which was recently published in Transplantation. The authors proposed peritransplant absolutely lymphocyte count (ALC) is a strong predictor for recurrence of hepatocellular carcinoma (HCC) after liver transplantation. In their investigation, peritransplant persistent lymphopenia was associated with increased risk of recurrence after liver transplantation. However, we suggested some issues should be clarified. Hepatocellular carcinoma frequently arises in the setting of cirrhosis. Patients with underlying cirrhosis may have hypersplenism, which may cause pancytopenia. In this situation, the pretransplant ALC of patients with HCC may be in a very low level. Moreover, for patients with severe hypersplenism or patients received a small for size graft during living donor liver transplantation, we may perform simultaneous liver transplantation and splenectomy (2, 3). Compared with pretransplant situation, the white blood cell counts, including ALC, will increase after splenectomy. However, Nagai et al. (1) did not mention whether hypersplenism and/or splenectomy are independent risk factors associated with peritransplant lymphopenia. Accordingly, the authors should explain whether their conclusion pertains to patients with HCC and hypersplenism, especially for patients who received simultaneous liver transplantation and splenectomy. We acknowledge that recipient’s immunization status plays a key role in overcoming HCC recurrence. In our previous study, we observed low pretransplant percentage of lymphocyte contributed to posttransplant HCC recurrence when we excluded patients with pretransplant infections (4). In our study, we used percentage of lymphocyte, but not ALC, because of both pancytopenia due to hypersplenism and white blood cell increasing after splenectomy could significantly impact the ALC but have less influence on percentage of lymphocyte. Infection is a common complication after liver transplantation, which could also affect the ALC of patients (5). For instance, the ALC of patients will significantly increase when patients experience postoperative virus infection after liver transplantation. However, this “high” level of ALC does not really mean that patients have a strong antitumor and immunomodulation abilities. Accordingly, the authors should exclude patients had peritransplant infections in the present study.